Skip to main content
OpenTrials

Clinical trial condition

Neoplasm Metastasis

Explore clinical trials studying Neoplasm Metastasis. Study availability and eligibility vary by location and protocol.

2,438 public trials 498 recruiting studies
Refine in advanced search Browse all conditions

Neoplasm Metastasis trial results

Active, Not Recruiting

Malignant Pleural Disease Treated With Autologous T Cells Genetically Engineered to Target the Cancer-Cell Surface Antigen Mesothelin

NCT02414269

Conditions
Adenoma, Breast Cancer, Breast Diseases, +21 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Consent and Follow-Up) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Consent and Follow-Up) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Consent and Follow-Up) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Commack (Consent and Follow-Up) Commack, New York, United States
View Trial Details
Active, Not Recruiting

A Study of Ramucirumab (LY3009806) or Merestinib (LY2801653) in Advanced or Metastatic Biliary Tract Cancer

NCT02711553

Conditions
Advanced Cancer, Biliary Tract Cancer, Biliary Tract Diseases, +10 more
Locations
  • The University of Arizona Cancer Center Tucson, Arizona, United States
  • UCSF Medical Center at Mission Bay San Francisco, California, United States
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
  • University of Florida School of Medicine Gainesville, Florida, United States
View all 82 locations
View Trial Details
Active, Not Recruiting

A Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Participants With ER+, HER2- Advanced Breast Cancer

NCT04975308

Conditions
Breast Diseases, Breast Neoplasms, Neoplasm Metastasis, +7 more
Locations
  • Ironwood Cancer & Research Centers Chandler, Arizona, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Marin Cancer Care Greenbrae, California, United States
  • University of California Davis (UC Davis) Comprehensive Cancer Center Sacramento, California, United States
View all 243 locations
View Trial Details
Active, Not Recruiting

Assess Efficacy & Safety of Selumetinib in Combination With Docetaxel in Patients Receiving 2nd Line Treatment for v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Positive NSCLC

NCT01933932

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
Locations
  • Research Site Aurora, Colorado, United States
  • Research Site Pembroke Pines, Florida, United States
  • Research Site Atlanta, Georgia, United States
  • Research Site Chicago, Illinois, United States
View all 197 locations
View Trial Details
Active, Not Recruiting

A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors

NCT06607185

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Solid Tumor, +53 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Mayo Clinic Phoenix, Arizona, United States
  • City of Hope Duarte, California, United States
  • University of California, Los Angeles (UCLA) Santa Monica, California, United States
View all 45 locations
View Trial Details

Related conditions